With the number of deaths from the Marburg virus lower than that of recoveries, Minister of Health Dr Sabin Nsanzimana has said the efforts to contain the outbreak are giving positive results.

Dr Nsanzimana said this during a briefing on the outbreak Sunday.

Since September 27, 61 cases of Marburg virus have been confirmed, 14 people have died and 27 individuals under treatment.

On Sunday, two people recovered from the disease bringing the total number to 20. No new cases or deaths were recorded.

"Three are in critical condition, but the rest are improving,” Nsanzimana said.

He expressed optimism about being able to contain the virus, which has mostly affected healthcare workers.

"Recoveries now outnumber deaths, which is a positive indication that our efforts are making an impact,” the minister said.

ALSO READ: 80% of Marburg cases are healthcare workers, says minister

To be considered recovered, patients must test negative twice, with tests spaced 72 hours apart, he noted.

"Our teams are working tirelessly to prevent patients from deteriorating into critical condition. Those under critical care are receiving the best possible treatment, with support from both local and international experts,” Dr Nsanzimana said.

Following the arrival of 1,000 more Marburg virus vaccines from the Sabin Vaccine Institute on Saturday, October 12, the vaccines are primarily aimed at healthcare workers and those in high-risk settings, particularly those working in intensive care units (ICUs) who face greater exposure.

ALSO READ: What to know about Marburg virus vaccine in use in Rwanda

More than about 700 people had received the vaccine by Sunday.

He explained that the vaccine is mainly intended to protect those most at risk of contracting the virus.

"The earlier we vaccinate them, the better for both their health and public safety," Dr Nsanzimana said, adding that the current vaccination program is in its second phase, focusing on efficacy.

"This phase is different from the first, which tested safety. We have seen the vaccine used in the US and East Africa, and so far, it has proven to be safe," he said.

"Most of those receiving the vaccine are healthcare professionals, and they are well-informed about its benefits and potential side effects.

"It is our responsibility, as the Ministry of Health, to ensure that every tool available is used to protect our citizens, especially against such a virus.”